HOME Top Market Reports Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018

By: marketsandmarkets.com
Publishing Date: February 2014
Report Code: BT 2236

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global gene expression market is segmented into instrumentation, consumables, and services. Based on technologies, the gene expression analysis instrumentation market is further segmented into DNA microarrays, real-time PCR, next-generation sequencing, and others. The consumables market is further categorized into DNA chips and reagents, while the services market is sub-segmented into gene expression profiling services, bioinformatics solutions, data analysis software, and others.

Based on applications, the global market is broadly categorized into diagnostics, drug discovery, biomarkers, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW). North America is the largest market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest rate over the next five years.

Over the years, the demand for gene expression has increased significantly owing to the increasing research on diseases like cancer, Alzheimer’s, and Parkinson’s. The technological advancements in the field of gene expression are expected to drive the global market in the coming years. Furthermore, advancements in sequencing platforms have also led to the decrease in the cost of sequencing. This is expected to boost the market as the amount of sequencing is likely to increase. The other factors that are driving the growth of the global market are the favorable funding scenario worldwide and increasing usage of gene expression analysis for medical research and diagnosis.

Another pivotal factor that drives the growth of the market is the increasing attention towards personalized medicine. The use of personalized medicine is believed to yield better results for treatments undertaken. Therefore, pharmaceutical companies are increasingly investing in personalized medicine research. However, the shortage of geneticists and high cost of equipment are factors hindering the market.

The major players in the global market include Affymetrix, Inc. (U.S.), Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), QIAGEN N.V.(Netherlands), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), GE Healthcare (U.K.), and Life Technologies (U.S.), among others.

Scope of the Report

This research report categorizes the global gene expression market into the following segments and sub-segments:

By Segment:

  • Instrumentation
  • Consumables
  • Services

By Technology:

  • DNA Microarrays
  • Real-Time PCR
  • Next Generation Sequencing
  • Others

By Product:

  • DNA Chips
    • Oligonucleotides
    • cDNA
  • Reagents

By Product:

  • Gene Expression Profiling Services
    • Sequencing Services
    • Microarray Services
    • qPCR Services
  • Bioinformatics Solutions
  • Data Analysis Software
  • Others

By Application:

  • Diagnostics
  • Drug Discovery
  • Academic Research
  • Biomarkers
  • Others

By Geography:

  • North America
  • Europe
  • Asia
  • RoW

Table Of Contents 
 
1 Introduction  (Page No. - 17)

  1.1 Objectives Of The Study
  1.2 Report Description
  1.3 Markets Covered
  1.4 Stakeholders
  1.5 Research Methodology
      1.5.1 Secondary Research
      1.5.2 Primary Research
            1.5.2.1 Key Data Points From Primary Sources
            1.5.3 Market Size Estimation
      1.5.4 Market Forecast
      1.5.5 Market Data Validation & Data Triangulation
  1.6 Assumptions

2 Executive Summary  (Page No. - 30)

3 Market Overview  (Page No. - 33)
  3.1 Introduction
  3.2 Market Dynamics
      3.2.1 Drivers
            3.2.1.1 Increasing Number Of Cancer Patients Globally
            3.2.1.2 Increase In Investments, Funds, And Grants By Government Bodies Worldwide
            3.2.1.3 Technological Advancements
            3.2.1.4 Small Rnas Gaining Momentum
            3.2.1.5 Gene Expression Databases To Aid Cancer Research
            3.2.1.6 Use Of Microarray Technology To Aid Gene Expression Studies
            3.2.1.7 Use Of Sbs Technology To Aid More Detailed Cancer Studies
      3.2.2 Restraints
            3.2.2.1 High Cost Of Instruments
            3.2.2.2 Dearth Of Technical Expertise
      3.2.3 Opportunities
            3.2.3.1 Rising Opportunities In Emerging Nations
            3.2.3.2 Growth In Personalized Medicine (Gene Therapy)
  3.3 Market Share Analysis
      3.3.1 By Key Players
  3.4 Value Chain Analysis
      3.4.1 Sequencing Platforms
  3.5 Market Analysis

4 Market By Segment  (Page No. - 52)
  4.1 Introduction

5 GEA Instrumentation Market, By Technology  (Page No. - 57)
  5.1 Introduction
  5.2 DNA Microarrays
  5.3 Real-Time Polymerase Chain Reaction (Rt-Pcr)
  5.4 Next Generation Sequencing
  5.5 Others
      5.5.1 Serial Analysis Of Gene Expression (Sage)
      5.5.2 Northern Blotting

6 GEA Consumables Market, By Product  (Page No. - 67)
  6.1 Introduction
  6.2 DNA Chips
      6.2.1 Oligonucleotides
      6.2.2 CDNA
  6.3 Reagents

7 GEA Services Market, By Product  (Page No. - 77)
  7.1 Introduction
  7.2 Gene Expression Profiling Services
      7.2.1 Sequencing Services
      7.2.2 Microarray Services
      7.2.3 Qpcr Services
  7.3 Bioinfomatics Solutions
  7.4 Data Analysis Software
  7.5 Others

8 GEA Market, By Application  (Page No. - 90)
  8.1 Introduction
  8.2 Diagnostics
  8.3 Drug Discovery
  8.4 Academic Research
  8.5 Biomarkers
  8.6 Others

9 Geographic Analysis  (Page No. - 100)
  9.1 Introduction
  9.2 North America
      9.2.1 Increased Funding For Medical Research
      9.2.2 Increasing Number Of Cancer Patients
      9.2.3 Reduction In The Cost Of Sequencing
  9.3 Europe
      9.3.1 Government Support, Collaborations, And Greenfield Investments To Trigger Market Growth In Turkey
      9.3.2 Reduced Government Funding In Europe To Put Pressure On Science And Research Activities
      9.3.3 Increasing Focus On Pharmacogenomics To Boost The Market In Europe
      9.3.4 Approvals And Developments In Gene Therapy To Propel Growth In The European Region
      9.3.5 The Sequencing Of 100,000 Genomes In The U.K. To Trigger Growth In The European Region
  9.4 Asia
      9.4.1 Growth In The Number Of Conferences And Exhibitions On Gene Expression To Boost The Asian Market
      9.4.2 Dominant Presence Of Singapore In The Market
      9.4.3 Gene Expression Signature For Quality Control Of Traditional Chinese Medicines
      9.4.4 Activities Of Beijing Genomics Institute (Bgi) Likely To Catapult The Chinese Market
      9.4.5 Collaborations Between Established Players And Local Organisations In China To Drive The Market
      9.4.6 The Rise Of The Indian Genomics Market
      9.4.7 Japan’s Increasing Focus On Cancer Research
  9.5 Rest Of The World (ROW)
      9.5.1 Funding Scenario In Middle East And Pacific Countries
      9.5.2 Increasing Focus On Hiv/Aids Genetic Resarch In Africa
      9.5.3 Focus Of South American Countries On Genomic Research To Imporve Public Health
      9.5.4 Growing Brazilian Market And Commitment To Gene Related Research To Boost The Market
      9.5.5 Growing Need Of Gene Expression Profiling To Understand And Combat Cancer In South America And Pacific Countries Is Likely To Propel The Market Growth

10 Competitive Landscape  (Page No. - 146)
   10.1 Introduction
   10.2 New Product Launch
   10.3 Agreements, Partnerships, Collaborations & Joint Ventures
   10.4 Mergers & Acquisitions
   10.5 Expansion

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 156)
   11.1 Affymetrix, Inc.
   11.2 Agilent Technologies
   11.3 Bio-Rad Laboratories, Inc.
   11.4 Ge Healthcare (Subsidiary Of General Electric Company)
   11.5 Illumina, Inc.
   11.6 Life Technologies
   11.7 Luminex Corporation
   11.8 Oxford Gene Technology, Inc.
   11.9 Perkinelmer, Inc.
   11.10 Qiagen N.V.
   11.11 Roche Diagnostics Corporation
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.  
   
List Of Tables  (72 Tables)
 
Table 1 Sampling Frame: Primary Research
Table 2 Global Gene Expression Market, By Segment, 2011–2018 ($Million) 
Table 3 By Geography, 2011–2018 ($Million) 
Table 4 Market By Technology, 2011–2018 ($Million) 
Table 5 Gene Expression Analysis Instrumentation Market, By Geography, 2011–2018 ($Million) 
Table 6 DNA Microarray Market, By Geography, 2011–2018 ($Million)
Table 7 Real-Time Pcr Market, By Geography, 2011–2018 ($Million)
Table 8 Next-Generation Sequencing market, By Geography, 2011–2018 ($Million) 
Table 9 Others Market, By Geography, 2011–2018 ($Million)
Table 10 Consumables Market, By Product, 2011–2018 ($Million) 
Table 11 Consumables Market, By Geography, 2011–2018 ($Million) 70
Table 12 Global Dna Chips Market, By Type, 2011–2018 ($Million)
Table 13 DNA Chips Market, By Geography, 2011–2018 ($Million)
Table 14 Oligonucleotides Market, By Geography, 2011–2018 ($Million)
Table 15 Complementary Dna Market, By Geography, 2011–2018 ($Million) 
Table 16 Reagents Market, By Geography, 2011–2018 ($Million)
Table 17 Global Gene Expression Analysis Services Market, By Product, 2011–2018 ($Million) 
Table 18 Market By Geography, 2011–2018 ($Million)
Table 19 Global Gene Expression Profiling Services Market, By Type, 2011–2018 ($Million) 
Table 20 Gene Expression Profiling Services Market, By Geography, 2011–2018 ($Million)
Table 21 Sequencing Services Market, By Geography, 2011–2018 ($Million) 
Table 22 Microarray Services Market, By Geography, 2011–2018 ($Million) 
Table 23 QPCR Services Market, By Geography, 2011–2018 ($Million)
Table 24 Bioinformatics Solutions Market, By Geography, 2011–2018 ($Million) 
Table 25 Data Analysis Software Market, By Geography, 2011–2018 ($Million) 
Table 26 Other Services Market, By Geography, 2011–2018 ($Million)
Table 27 Market By Application, 2011–2018 ($Million)
Table 28 Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 29 Drug Discovery Market, By Geography, 2011–2018 ($Million) 
Table 30 Gene Expression Analysis Academic Research Market, By Geography, 2011–2018 ($Million) 
Table 31 Biomarkers Market, By Geography, 2011–2018 ($Million)
Table 32 Others Market, By Geography, 2011–2018 ($Million)
Table 33 Market By Geography, 2011–2018 ($Million) 
Table 34 Instrumentation Market, By Geography, 2011–2018 ($Million) 
Table 35 Consumables Market, By Geography, 2011–2018 ($Million) 
Table 36 Gene Expression Analysis Services Market, By Geography, 2011–2018 ($Million)
Table 37 North America: Gene Expression Market, By Segment, 2011–2018 ($Million) 
Table 38 North America: By Country, 2011–2018 ($Million)
Table 39 North America: Instrumentation Market, By Country, 2011–2018 ($Million)
Table 40 North America: Consumables Market, By Country, 2011–2018 ($Million)
Table 41 North America: GEA Services Market, By Country, 2011–2018 ($Million) 
Table 42 North America: By Application, 2011–2018 ($Million) 
Table 43 North America: By Technology, 2011–2018 ($Million)
Table 44 North America: Consumables Market, By Product, 2011–2018 ($Million)
Table 45 North America: DNA Chips Market, By Type, 2011–2018 ($Million) 
Table 46 North America: GEA Services Market, By Product, 2011–2018 ($Million) 
Table 47 North America: Gene Expression Profiling Services Market, By Type, 2011–2018 ($Million)
Table 48 Europe: Gene Expression Market, By Segment, 2011–2018 ($Million) 
Table 49 Europe: By Application, 2011–2018 ($Million)
Table 50 Europe: Instrumentation Market, By Technology, 2011–2018 ($Million)
Table 51 Europe: Consumables Market, By Product, 2011–2018 ($Million) 
Table 52 Europe: DNA Chips Market, By Type, 2011–2018 ($Million)
Table 53 Europe: GEA Services Market, By Product, 2011–2018 ($Million) 
Table 54 Europe: Gene Expression Profiling Services Market, By Type, 2011–2018 ($Million) 
Table 55 Asia: Gene Expression Market, By Segment, 2011–2018 ($Million) 
Table 56 Asia: By Application, 2011–2018 ($Million) 
Table 57 Asia: Instrumentation Market, By Technology, 2011–2018 ($Million) 
Table 58 Asia: Consumables Market, By Product, 2011–2018 ($Million) 
Table 59 Asia: DNA Chips Market, By Type, 2011–2018 ($Million)
Table 60 Asia: GEA Services Market, By Product, 2011–2018 ($Million) 
Table 61 Asia: Gene Expression Profiling Services Market, By Type, 2011–2018 ($Million) 
Table 62 Row: Gene Expression Market, By Segment, 2011–2018 ($Million) 
Table 63 Row: By Application, 2011–2018 ($Million) 
Table 64 Row: Instrumentation Market, By Technology, 2011–2018 ($Million) 
Table 65 Row: Consumables Market, By Product, 2011–2018 ($Million) 
Table 66 Row: DNA Chips Market, By Type, 2011–2018 ($Million)
Table 67 Row: GEA Services Market, By Product, 2011–2018 ($Million) 
Table 68 Row: Gene Expression Profiling Services Market, By Type, 2011–2018 ($Million) 
Table 69 New Product Launch (January 2011–June 2013)
Table 70 Agreements, Partnerships, Collaborations, Contracts, And Joint Ventures (January 2011–June 2013)
Table 71 Mergers And Acquisitions (January 2011–June 2013)
Table 72 Expansion (January 2011–June 2013) 
 
List Of Figures (20 Figures)
  
Figure 1 Research Methodology For The Market
Figure 2 Market Size Estimation Methodology
Figure 3 Market Sizing ($Value Analysis)
Figure 4 Competitive Assessment (Market Share/Strategies Assessment For GEA Products)
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Segment, 2013
Figure 7 Gene Expression Market, 2013
Figure 8 Market Dynamics
Figure 9 Market Share Analysis, By Key Players
Figure 10 Value Chain Analysis For Sequencing Platforms
Figure 11 Market By Application (2013)
Figure 12 Market Segmentation
Figure 13 Instrumentation Market, By Technology 
Figure 14 Consumables Market Segmentation
Figure 15 GEA Services Market Segmentation
Figure 16 Market By Application
Figure 17 Market Geographical Ranking, 2013
Figure 18 Key Growth Strategies In Market, 2011–2013
Figure 19 Key Players Focusing On The New Product Launch Strategy, 2011–2013
Figure 20 Key Players Focusing On The Strategy Of Agreements, Collaborations, Partnerships, Contracts, And Joint Ventures, 2011–2013

Customization TOC for Gene Expression Analysis Market

Country wise data can be given as customization:

North America

  • U.S
  • Canada

Europe

  • EU-5
  • Rest of Europe

Asia

  • China
  • Japan
  • India
  • Rest of Asia

Rest of World

  • Latin America
  • Africa
  • Middle East
  • Pacific Countries

Gene expression analysis has emerged as a major advancement in the fields of drug discovery, diagnostics, and biomedical research. Since the completion of the Human Genome Project in 2003, numerous methods are being developed to improve the efficiency and effectiveness of gene expression profiling and sequencing. it is an important process, as it enables researchers to decipher the functions of genes. By sequencing genes, researchers can determine how diseases affect a cell. Genome-wide analysis can be used to accurately classify diseases. This has led to its increased use in various applications such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers.

This report broadly categorizes the global market into three segments, namely, instrumentation, consumables, and services. The large share of consumables is specifically attributed to the wide use of gene expression analysis techniques in cancer diagnostics. The increase in the number of genetic tests directly favors volume consumption of consumables. The gene expression services market is expected to grow at the highest CAGR of XX% from 2013 to 2018. This high growth can be attributed to the growing adoption of next-generation sequencing, advancements in bioinformatics tools, and the declining cost of sequencing.

Over the years, gene expression analysis has evolved significantly and is widely used for the diagnosis and treatment of various disorders like cancer, Alzheimer’s, and Parkinson’s, among others. In the past few years, the market has witnessed significant technological advancements, as companies have introduced newer sequencing and analysis platforms. This has aided in the diagnosis and treatment of diseases. This report covers the definition, description, and forecast of the global market in terms of instrumentation, consumables, services, and applications.

Gene Expression Market, By Geography, 2013 - 2018

 Gene Expression Analysis Market

Source: MarketsandMarkets Analysis

The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market.

Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global market.

 

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports